Osaic Holdings’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
Other funds holding GTBP
HF
EFG
AAP
OWA
4WM
A
Osaic Holdings's GTBP Position: Q2 2026 in Review
Osaic Holdings increased its GT Biopharma (GTBP) stake by 83% in Q2 2026, buying an estimated $7.1K and bringing the position to 38,500 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6217.
Osaic Holdings first reported a position in GTBP in Q1 2021 and has held it in 22 quarters since. The position peaked at $45K in Q2 2021. 59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.
- Osaic Holdings held 38,500 shares of GT Biopharma worth $18.9K as of Q2 2026.
- Osaic Holdings bought 17,500 GT Biopharma shares in Q2 2026, an estimated $7.1K.
- GT Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6217 holding.
- Osaic Holdings first reported a position in GT Biopharma in Q1 2021 and has held it in 22 quarters since.
- Osaic Holdings's GT Biopharma position peaked at $45K in Q2 2021.
- 59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.